Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3315104 | 1.00 | GPR84 (0.42) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3124230 | 0.87 | FFAR1 (0.42) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL5102224 | 0.87 | TSHR (0.37) | — | |
| SCHEMBL4893257 | 0.85 | CES2 (0.47) | FFAR1FFAR4 | |
| SCHEMBL6835540 | 0.84 | SLC6A3 (0.36) | FDPS | |
| SCHEMBL1890854 | 0.82 | GPR84 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1960267 | 0.82 | GPR84 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1961630 | 0.82 | GPR84 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1961371 | 0.82 | GPR84 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8629737 | 0.82 | GPR84 (0.53) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9487519-B2 | 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | BASF SE (DE) | 2016-11-08 | — | — | US | disclosed |
| EP-1725561-B1 | 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS | BASF SE (DE) | 2010-07-07 | — | — | EP | disclosed |
| US-20080139581-A1 | 2-Substituted 7-Aminoazolopyrimidines, Processes For Their Preparation And Their Use For Controlling Harmful Fungi, And Compositions Comprising These Compounds | BASF AKTIENGESELLSCHAFT (DE) | 2008-06-12 | — | — | US | disclosed |
| EP-1856122-A2 | 2-SUBSTITUTED 7-AMINO-AZOLOPYRIMIDINE, A METHOD FOR THE PRODUCTION AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-21 | — | — | EP | disclosed |
| US-20070173408-A1 | 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | BASF SE (DE) | 2007-07-26 | — | — | US | disclosed |
| EP-1725561-A1 | 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-29 | — | — | EP | disclosed |
| WO-2006092428-A2 | 2-SUBSTITUTED 7-AMINO-AZOLOPYRIMIDINE, A METHOD FOR THE PRODUCTION AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-08 | — | — | WO | disclosed |
| WO-2005087773-A1 | 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173408-A1 | 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | ERG28, DPM1, ATL3 | GPR84 4205/4885FFAR1 3799/4885MAPT 1799/4885 |
| US-20080139581-A1 | 2-Substituted 7-Aminoazolopyrimidines, Processes For Their Preparation And Their Use For Controlling Harmful Fungi, And Compositions Comprising These Compounds | CBR3, CROCC, PRXL2A | GPR84 3077/4885FFAR1 3438/4885MAPT 4637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.